Clinical trial

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital

NCT00320762

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-01-01

PhasePHASE3

Study timeline

Study start (unknown)2006-01-01Date precision: month

Registry last updated2008-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Pterygiumunresolved

Interventions

OculusGen Biodegradable Collagen Matrix ImplantDEVICE

Sponsors & collaborators

Pro Top & Mediking Company Limitedlead sponsor

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00320762 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.